Related Experiment Video
Updated: Jan 13, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Linezolid-resistant and vancomycin-resistant Enterococcus faecium urinary isolate in a pediatric B-ALL patient
Emma Seevak1, Tanvi S Sharma1,2, Alaric W D'Souza1,2,3
1Harvard Medical School, Boston, Massachusetts, USA.
Linezolid resistance in Vancomycin-resistant Enterococcus faecium (VRE) presents treatment challenges, especially in immunocompromised patients. This case highlights the need for accurate susceptibility testing to guide therapy for VRE infections.
Area of Science:
- Infectious Diseases
- Antimicrobial Resistance
- Clinical Microbiology
Background:
- Vancomycin-resistant Enterococcus faecium (VRE) is a significant cause of healthcare-associated infections.
- Linezolid is a crucial antibiotic for treating resistant Gram-positive bacteria, including VRE.
- Emerging linezolid resistance in VRE poses a serious threat to treatment options, particularly in vulnerable populations.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection IV: Nursing Management
Development of Antibiotic Resistance
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Antimicrobial Effectiveness
Urinary Tract Infection II: Pathophysiology

